Cargando…

Pre-transplant testosterone and outcome of men after allogeneic stem cell transplantation

Testosterone is an important determinant of endothelial function and vascular health in men. As both factors play a role in mortality after allogeneic stem cell transplantation (alloSCT), we retrospectively evaluated the impact of pre-transplant testosterone levels on outcome in male patients underg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radujkovic, Aleksandar, Kordelas, Lambros, Krzykalla, Julia, Benner, Axel, Schult, David, Majer-Lauterbach, Joshua, Beelen, Dietrich W., Müller-Tidow, Carsten, Kasperk, Christian, Dreger, Peter, Luft, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193480/ https://www.ncbi.nlm.nih.gov/pubmed/31296579 http://dx.doi.org/10.3324/haematol.2019.220293

Ejemplares similares

Interleukin-18 and outcome after allogeneic stem cell transplantation: A retrospective cohort study
por: Radujkovic, Aleksandar, et al.
Publicado: (2019)

Interleukin-18 and Hematopoietic Recovery after Allogeneic Stem Cell Transplantation
por: Radujkovic, Aleksandar, et al.
Publicado: (2020)

Pre-Transplant Serum Leptin Levels and Relapse of Acute Myeloid Leukemia after Allogeneic Transplantation
por: Schwarzbich, Mark-Alexander, et al.
Publicado: (2022)

Asymmetric dimethylarginine serum levels are associated with early mortality after allogeneic stem cell transplantation
por: Radujkovic, Aleksandar, et al.
Publicado: (2019)

Early bilirubinemia after allogeneic stem cell transplantation—an endothelial complication
por: Dai, Hao, et al.
Publicado: (2021)

Predicting sinusoidal obstruction syndrome after allogeneic stem cell transplantation with the EASIX biomarker panel
por: Jiang, Sihe, et al.
Publicado: (2020)

EASIX-1year and late mortality after allogeneic stem cell transplantation
por: Kordelas, Lambros, et al.
Publicado: (2023)

Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation
por: Luft, Thomas, et al.
Publicado: (2021)

Pre-transplant weight loss predicts inferior outcome after allogeneic stem cell transplantation in patients with myelodysplastic syndrome
por: Radujkovic, Aleksandar, et al.
Publicado: (2015)

Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation
por: Korell, Felix, et al.
Publicado: (2022)

Response to Vaccination with Sars-CoV2 Vaccines in Patients Post Allogeneic Hematopoietic Cell Transplantation
por: Pabst, Caroline, et al.
Publicado: (2022)

Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data
por: Derigs, Patrick, et al.
Publicado: (2020)

The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease
por: Kordelas, Lambros, et al.
Publicado: (2016)

Humoral Responses and Chronic GVHD Exacerbation after COVID-19 Vaccination Post Allogeneic Stem Cell Transplantation
por: Pabst, Caroline, et al.
Publicado: (2022)

Low Soluble Programmed Cell Death Protein 1 Levels After Allogeneic Stem Cell Transplantation Predict Moderate or Severe Chronic GvHD and Inferior Overall Survival
por: Kordelas, Lambros, et al.
Publicado: (2021)

Decreased Soluble Human Leukocyte Antigen E Levels in Patients After Allogeneic Hematopoietic Stem Cell Transplantation Are Associated With Severe Acute and Extended Chronic Graft-versus-Host Disease and Inferior Overall Survival
por: Kordelas, Lambros, et al.
Publicado: (2020)

EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy—A Cohort Study
por: Korell, Felix, et al.
Publicado: (2022)

Cure of intravascular NK/T-cell lymphoma of the central nervous system by allogeneic hematopoietic cell transplantation
por: Meissner, Julia, et al.
Publicado: (2022)

Influencing factors of cardiorespiratory fitness in allogeneic stem cell transplant candidates prior to transplantation
por: Limbach, Matthias, et al.
Publicado: (2020)

Clinical Response to the CD95-Ligand Inhibitor Asunercept Is Defined by a Pro-Inflammatory Serum Cytokine Profile
por: Radujkovic, Aleksandar, et al.
Publicado: (2020)

Kynurenine pathway activation and deviation to anthranilic and kynurenic acid in fibrosing chronic graft-versus-host disease
por: Orsatti, Laura, et al.
Publicado: (2021)

Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD
por: Dai, Hao, et al.
Publicado: (2021)

EASIX for prediction of survival in lower-risk myelodysplastic syndromes
por: Merz, Almuth, et al.
Publicado: (2019)

EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients
por: Luft, Thomas, et al.
Publicado: (2021)

Editorial: “The Role of Immune Checkpoint Molecules in Solid and Hematopoietic Stem Cell Transplantation”
por: Kordelas, Lambros, et al.
Publicado: (2021)

Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
por: Robin, Marie, et al.
Publicado: (2019)

Intestinal T lymphocyte homing is associated with gastric emptying and epithelial barrier function in critically ill: a prospective observational study
por: Greis, Christian, et al.
Publicado: (2017)

Correlation of nutrition-associated parameters with non-relapse mortality in allogeneic hematopoietic stem cell transplantation
por: Schaffrath, Judith, et al.
Publicado: (2021)

Individual Immune-Modulatory Capabilities of MSC-Derived Extracellular Vesicle (EV) Preparations and Recipient-Dependent Responsiveness
por: Kordelas, Lambros, et al.
Publicado: (2019)

Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
por: Sellner, Leopold, et al.
Publicado: (2020)

Validation of pre-conditioning EASIX for prediction of sepsis after allogeneic stem cell transplantation
por: Korell, Felix, et al.
Publicado: (2023)

Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
por: Sellner, Leopold, et al.
Publicado: (2021)

Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation
por: Gagelmann, Nico, et al.
Publicado: (2019)

Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
por: Schuler, Esther, et al.
Publicado: (2020)

Combined Analysis of Early CD4(+) T Cell Counts and CMV Serostatus May Improve CMV Risk Assessment after Allogeneic Hematopoietic Cell Transplantation
por: Leserer, Saskia, et al.
Publicado: (2021)

Significance of men’s health in long-term survivors of allogeneic stem cell transplantation
por: Schneidewind, Laila, et al.
Publicado: (2022)

Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcome
por: Katzerke, Christiane, et al.
Publicado: (2023)

Risk Factors Influencing Humoral Response to COVID 19 Vaccination after Allogeneic Stem Cell Transplantation
por: Hütter-Krönke, Marie Luise, et al.
Publicado: (2022)

Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia
por: Kayser, S, et al.
Publicado: (2016)

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies
por: Pflug, Natali, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ehq071dvu1f8o8kolc3mhvc5iq